The effects of drugs that treat Alzheimer’s, cancer and other illnesses are often limited by the blood-brain barrier. The New York Times reports on a study at the WVU Rockefeller Neuroscience Institute suggesting a new way to address that barrier.
The effects of drugs that treat Alzheimer’s, cancer and other illnesses are often limited by the blood-brain barrier. The New York Times reports on a study at the WVU Rockefeller Neuroscience Institute suggesting a new way to address that barrier.